# C_2010053EN.01000801.xml

| 3.3.2010 | EN | Official Journal of the European Union | C 53/8 |
| --- | --- | --- | --- |

3.3.2010

EN

Official Journal of the European Union

C 53/8

---

Prior notification of a concentration

(Case COMP/M.5777 — Drägerwerk/Dräger Medical)

Candidate case for simplified procedure

(Text with EEA relevance)

2010/C 53/04

| 1. | On 23 February 2010, the Commission received a notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) by which the undertaking Drägerwerk AG & Co. KGaA (‘Drägerwerk’, Germany) acquires within the meaning of Article 3(1)(b) of the EC Merger Regulation control of the whole of the undertaking Dräger Medical AG & Co. KG (‘Dräger Medical’, Germany) by way of purchase of shares. |
| --- | --- |

1.

On 23 February 2010, the Commission received a notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) by which the undertaking Drägerwerk AG & Co. KGaA (‘Drägerwerk’, Germany) acquires within the meaning of Article 3(1)(b) of the EC Merger Regulation control of the whole of the undertaking Dräger Medical AG & Co. KG (‘Dräger Medical’, Germany) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | Drägerwerk is the holding company of the Dräger Group, which is active in the fields of medical and safety technology, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

Drägerwerk is the holding company of the Dräger Group, which is active in the fields of medical and safety technology,

| — | Dräger Medical develops, produces and distributes products, services and integrated system solutions for intensive and home care. The main focus is on the production of anaesthesia workstations, ventilation equipment, and patient monitors including equipment as well as services and maintenance of these products. |
| --- | --- |

—

Dräger Medical develops, produces and distributes products, services and integrated system solutions for intensive and home care. The main focus is on the production of anaesthesia workstations, ventilation equipment, and patient monitors including equipment as well as services and maintenance of these products.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.5777 — Drägerwerk/Dräger Medical, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.5777 — Drägerwerk/Dräger Medical, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

1

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

2

---